SEINE BIO · Research, evidence & your next steps
A closer look at fat-metabolism research.
AOD9604 was developed to explore a focused fragment of growth-hormone biology. Its research history helps clarify how an appealing mechanism compares with demonstrated weight-management outcomes.
This catalog formulation is investigational, not an FDA approved treatment.
How AOD9604 works
AOD9604 is a modified fragment derived from human growth hormone and was investigated for effects on lipid metabolism. It should not be assumed to reproduce every action of growth hormone or to be a proven non-hormonal fat-loss treatment.
Why it’s getting attention
FDA’s compounding review describes limited clinical evidence and lack of clinically meaningful weight-loss benefit across the later trial population. The evidence does not support promising targeted fat loss, a leaner physique or an established injectable weight-management protocol.
Protocol reference at a glance
Reference context, not your prescription. No established patient protocol was identified for this formulation. The chart summarizes research context, not directions for use.
| Stage | What to expect from the evidence |
|---|---|
| Research setting | Historical development included routes and formulations that do not establish a standard subcutaneous home regimen. |
| Starting / loading phase | No validated routine-care starting or loading dose established for this exact formulation. |
| Standard dose / maximum | No validated standard patient dose or safe maximum established here. |
| Maintenance / cycles | No validated ongoing maintenance or cycling protocol identified. |
Presentation & administration
Route-specific evidence is essential. Oral study experience, a laboratory peptide and a SEINE BIO injectable presentation are not automatically interchangeable.
Catalog presentation: Vial / Cartridge / Disposable Injection Pen. Listed strength options: 5 mg. One catalog unit is one selected presentation—not a box containing every pictured format. Total container content is not a personal dose, and an illustration does not verify an approved route or device.
Risks & common side effects
- Reliable adverse-effect rates for this exact catalog formulation are not established. A lack of reported events is not proof of safety.
- Identity, peptide impurities and immune-response risk require assessment, particularly for injectable formulations. Do not describe it as risk-free because it is a hormone fragment.
Tell your clinician about new or persistent symptoms and other medicines. Changes to treatment should be clinician-directed.
Other options worth discussing
Approved obesity medicines and individualized nutrition, activity and weight-management support are better-established options than a fat-burning claim built on a fragment’s mechanism. “More established” does not mean risk-free or suitable for everyone; a clinician should compare benefits, contraindications and your preferences.
When to seek help
Persistent symptoms, an unexpected reaction or signs of infection need prompt medical attention.
Finished-product quality, concentration and route require verification. Review allergies, pregnancy, health conditions and other medicines with your clinician.
Do not wait for a portal reply in an emergency. Call 911 or seek emergency care for severe or rapidly worsening symptoms.
A few useful answers
Is it proven to remove belly fat?
No. The reviewed human evidence does not establish reliable or targeted weight loss.
Does it avoid all growth-hormone risks?
That cannot be guaranteed. A different molecule still needs its own safety and formulation evidence.
Does clinician authorization guarantee access?
No. Clinical appropriateness, lawful availability and a verified finished formulation must each be established. An Rx setting, luxury image or research-series label does not create regulatory approval.
Research & references
General information, not a prescription or a guarantee of results. Research and reference-label schedules do not replace instructions for your exact prescribed product. Clinical suitability and lawful availability require separate confirmation.
Make your next step an informed one.
Share what you want to improve, what you have already tried, and the questions you have about AOD9604. Your care team can help put the evidence and alternatives in context.
Sign-in may be required. This is not an emergency service or a guarantee that this product is available.